Selected
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
2572 results found
2023 ∙ Zhou, H. Ye, Q.
Clinical Features of COVID-19 Vaccine-Associated Autoimmune Hepatitis: A Systematic Review
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Chenchula, S. Amerneni, K. C. Ghanta, M. K. Padmavathi, R. Chandra, M. B. Adusumilli, M. B. Chavan, M. Mudda, S. Gupta, R. Lakhawat, B.
Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Fortier, L. M. Smith, K. L. Ina, J. G. Sinkler, M. A. Calcei, J. G. Salata, M. J. Gillespie, R. Voos, J. E.
Common Characteristics of Shoulder Injury Related to Vaccine Administration (SIRVA) Following COVID-19 Vaccination: A Comprehensive Systematic Review
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Oketch, Sandra Y. Ochomo, Edwin O. Orwa, Jeniffer A. Mayieka, Lilian M. Abdullahi, Leila H.
Communication strategies to improve human papillomavirus (HPV) immunisation uptake among adolescents in sub-Saharan Africa: a systematic review and meta-analysis
  • Adolescents
  • Parents/caregivers
  • Healthcare workers
  • Human papillomavirus (HPV)
  • Acceptance
  • Coverage
Rating:
Not applicable
2023 ∙ Wang, X. Haeussler, K. Spellman, A. Phillips, L. E. Ramiller, A. Bausch-Jurken, M. T. Sharma, P. Krivelyova, A. Vats, S. Van de Velde, N.
Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Lin, R. Jin, H. Fu, X.
Comparative efficacy of human papillomavirus vaccines: systematic review and network meta-analysis
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Administration
Rating:
Critically low
2023 ∙ Hossaini, S. Keramat, F. Cheraghi, Z. Zareie, B. Doosti-Irani, A.
Comparing the Efficacy and Adverse Events of Available COVID-19 Vaccines Through Randomized Controlled Trials: Updated Systematic Review and Network Meta-analysis
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Rating:
Critically low
2023 ∙ Kuziez, L. Eleiwa, T. K. Chauhan, M. Z. Sallam, A. B. Elhusseiny, A. M. Saeed, H. N.
Corneal Adverse Events Associated with SARS-CoV-2/COVID-19 Vaccination: A Systematic Review
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Teferi, G. Kefale, B.
Coronavirus vaccine acceptance in Ethiopia: Systematic review and meta-analysis
  • Vaccine/vaccination
  • All age groups
  • Healthcare workers
  • Pregnant women
  • Ethiopia
  • COVID-19
  • Acceptance
Rating:
Not applicable
2023 ∙ Zhou, Q. Liu, Y. Zeng, F. Meng, Y. Liu, H. Deng, G.
Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Rating:
Moderate